Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Atherosclerotic Cardiovascular Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02719652
What this trial is testing

Vessel Wall and Perfusion Imaging in Intracranial Atherosclerosis

Who this might be right for
Intracranial Atherosclerosis
Xiuhai Guo 300
Post-approval studies (Phase 4)UnknownNCT02458755
What this trial is testing

Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis

Who this might be right for
StrokeIntracranial Atherosclerosis
Samsung Medical Center 80
Large-scale testing (Phase 3)Ended earlyNCT04007055
What this trial is testing

The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions

Who this might be right for
Peripheral Artery DiseaseClopidogrel, Poor Metabolism ofPeripheral Vascular Disease+2 more
Marissa Jarosinski 31
Not applicableStudy completedNCT00520962
What this trial is testing

Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk

Who this might be right for
Diabetes Mellitus, Type 2
IRCCS San Raffaele 1,997
Not applicableStudy completedNCT00862056
What this trial is testing

Detection of Subclinical Atherosclerosis in Asymptomatic Individuals

Who this might be right for
Coronary Artery Disease
Piedmont Healthcare 73
Not applicableUnknownNCT03855436
What this trial is testing

Risk Factors of Intermediate Coronary Lesion Progression

Who this might be right for
Coronary AtherosclerosesCoronary Angiography
China National Center for Cardiovascular Diseases 1,389
Large-scale testing (Phase 3)Study completedNCT00080275
What this trial is testing

Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)

Who this might be right for
Hypercholesterolemia
Kos Pharmaceuticals 600
Testing effectiveness (Phase 2)Study completedNCT00768274
What this trial is testing

Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol

Who this might be right for
DyslipidemiaAtherosclerosisAcute Coronary Syndrome+1 more
Resverlogix Corp 72
Not applicableLooking for participantsNCT03504956
What this trial is testing

Coronary Atherosclerosis T1-Weighted Characterization (CATCH)

Who this might be right for
Coronary Atherosclerosis
Cedars-Sinai Medical Center 150
Not applicableLooking for participantsNCT07252830
What this trial is testing

Identification of Asymptomatic Patients at Very High Cardiovascular Risk: Contribution of a Strategy Based on Carotid and Coronary Explorations, Compared to Simple Risk Calculation Using the European "SCORE 2" Algorithm. (IDEA-CVR)

Who this might be right for
Myocardial InfarctionAtheromaCholesterol+1 more
Elsan 1,000
Not applicableNot Yet RecruitingNCT07460583
What this trial is testing

ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes

Who this might be right for
Coronary Atherosclerosis Due to Calcified Coronary Lesion
Baylor Research Institute 100
Not applicableActive Not RecruitingNCT07599540
What this trial is testing

Cardiovascular Risk in Peripheral Artery Disease Patients Undergoing Endovascular Revascularisation

Who this might be right for
Peripheral Arterial DiseaseMyocardial InjuryTroponin+6 more
University Medical Centre Ljubljana 500
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Post-approval studies (Phase 4)Study completedNCT03096288
What this trial is testing

Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity

Who this might be right for
Atherosclerotic Cardiovascular Disease
University of Florida 259
Early research (Phase 1)Looking for participantsNCT07428473
What this trial is testing

STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Elevated LDL-C and High Cholesterol
Monash University 64
Large-scale testing (Phase 3)Study completedNCT00189111
What this trial is testing

Non-invasive Cardiac Screening in High Risk Patients -The GROUND Study

Who this might be right for
Peripheral Arterial Disease
Clinical Research Office Imaging Division 1,200
Post-approval studies (Phase 4)Not Yet RecruitingNCT07762755
What this trial is testing

Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT

Who this might be right for
Coronary Artery DiseaseHyperlipidaemiaHypertriglyceridaemia+1 more
China National Center for Cardiovascular Diseases 100
Not applicableStudy completedNCT01208025
What this trial is testing

ParisK: Validation of Imaging Techniques

Who this might be right for
StrokeAtherosclerosis
Maastricht University Medical Center 244
Not applicableStudy completedNCT00861653
What this trial is testing

Atherosclerotic Plaque Characterization

Who this might be right for
Atherosclerosis
Piedmont Healthcare 50
Large-scale testing (Phase 3)Study completedNCT04807400
What this trial is testing

Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support

Who this might be right for
Atherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease Risk EquivelentsElevated Low Density Lipoprotein Cholesterol
Novartis Pharmaceuticals 892
Next Page